AC8 0.00% 4.0¢ auscann group holdings ltd

The Licence follows the Australian cultivation licences that...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 113 Posts.
    The Licence follows the Australian cultivation licences that have been granted for the Company’s site in Western Australia (announced 5 May 2017), and in Tasmania through its strategic partnership with Tasmanian Alkaloids (announced 11 July 2017). The Company and its strategic partner, Tasmanian Alkaloids, are awaiting the outcome of a further manufacturing licence application for the proposed operations in Tasmania.

    So the license granted for ac8, which supposedly for the 'future' WA facility. Manufacturing at the tasalk facility is still under application. So much into believing that they are actually ready to manufacture locally...

    I would still prefer an update ann in regards to their WA facility.
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.